PLXProtalix BioTherapeutics, Inc.

NYSE protalix.com


$ 1.12 $ -0.01 (-0.88 %)    

Friday, 31-May-2024 15:59:26 EDT
QQQ $ 454.82 $ -0.84 (-0.19 %)
DIA $ 398.57 $ 6.05 (1.59 %)
SPY $ 530.36 $ 4.76 (0.91 %)
TLT $ 91.26 $ 0.61 (0.68 %)
GLD $ 225.37 $ -1.27 (-0.59 %)
$ 1.13
$ 1.15
$ 0.00 x 0
$ 0.00 x 0
$ 1.12 - $ 1.15
$ 1.03 - $ 2.51
345,304
na
82.53M
$ 0.99
$ 12.05
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 03-14-2024 12-31-2023 10-K
3 11-06-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-27-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-31-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-14-2021 03-31-2021 10-Q
14 03-30-2021 12-31-2020 10-K
15 10-29-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 06-01-2020 03-31-2020 10-Q
18 03-12-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-06-2019 03-31-2019 10-Q
22 03-18-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-09-2018 03-31-2018 10-Q
26 03-06-2018 12-31-2017 10-K
27 11-08-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 03-16-2017 12-31-2016 10-K
31 11-09-2016 09-30-2016 10-Q
32 08-08-2016 06-30-2016 10-Q
33 05-09-2016 03-31-2016 10-Q
34 03-08-2016 12-31-2015 10-K
35 11-09-2015 09-30-2015 10-Q
36 08-10-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 03-12-2015 12-31-2014 10-K
39 11-10-2014 09-30-2014 10-Q
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 protalix-biotherapeutics-q4-gaap-eps-007-misses-003-estimate-sales-1049m-beat-580m-estimate

Protalix BioTherapeutics (AMEX:PLX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate ...

 earnings-scheduled-for-march-14-2024

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

 hc-wainwright--co-reiterates-buy-on-protalix-biotherapeutics-maintains-10-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Protalix BioTherapeutics (AMEX:PLX) with a Buy and maintains $...

 earnings-scheduled-for-november-6-2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on ...

 protalix-biotherapeutics-q3-eps-004-inline-sales-1035m-beat-1000m-estimate

Protalix BioTherapeutics (AMEX:PLX) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. Th...

 hc-wainwright--co-maintains-buy-on-protalix-biotherapeutics-raises-price-target-to-10

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Protalix BioTherapeutics (AMEX:PLX) with a Buy and raises the p...

 protalix-biotherapeutics-and-2-other-penny-stocks-insiders-are-buying

The Dow Jones closed lower by around 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence...

 protalix-biotherapeutics-says-operations-have-not-been-adversely-affected-by-current-security-situation-in-israel

"Hostilities have not taken place where Protalix's facilities are located and we do not anticipate any disruption to th...

 protalix-biotherapeutics-appoints-eliot-richard-forster-as-chairman-of-its-board--effective-as-of-september-14-2023

Zeev Bronfeld, the current Chairman of the Company's Board of Directors, will retire on the same day.

 watching-protalix-biotherapeutics-zacks-small-cap-research-sets-16-price-valuation

https://scr.zacks.com/files/News/2023/Zacks_SCR_Research_08082023_PLX_Vandermosten.pdf

 protalix-biotherapeutics-q2-eps-021-beats-004-estimate-sales-3508m-beat-1022m-estimate

Protalix BioTherapeutics (AMEX:PLX) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of...

 earnings-scheduled-for-august-7-2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report quarterly loss at $0.44 per share on revenu...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION